Data from a recent study indicate that further extension of COVID-19 pandemic–era prescribing rules, referred to as “Notice of Proposed Rulemaking” (NPRM), would better treat patients suffering from opioid use disorder (OUD) and be more cost-effective than reverting to pre-pandemic regulations.
Last year the Drug Enforcement Administration, in collaboration with the Department of Health and Human Services, temporarily extended the authorization of all registered practitioners